Latham & Watkins Advises Ardian in its Strategic Investment in ANGUS Chemical Company from Golden Gate Capital

A multidisciplinary team advised the private investment firm in the transaction.

October 14, 2020

Ardian, a world leading private investment house, has announced that it has acquired a 50-percent ownership stake in ANGUS Chemical Company from Golden Gate Capital. Golden Gate Capital, which initially acquired ANGUS in February 2015 from The Dow Chemical Company, will retain a 50-percent stake in ANGUS. Additional terms of the transaction were not disclosed.

Latham & Watkins LLP represents Ardian in the transaction with a corporate deal team led by New York partner David Kurzweil and Paris/London partner Gaëtan Gianasso, with New York associates Leah Sauter, Adam Rosenthal and Daniel Goldschmidt. Advice was also provide on tax matters by New York partner Lisa Watts; on employee benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum; and on antitrust matters by Paris partner Adrien Giraud.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.